** Laboratory Corporation of America Holdings' shares LH.N
up 3.74% premarket to $258.80
** Co to spin off its clinical development business into
separately listed firm urn:newsml:reuters.com:*:nL4N2Z92UQ
** Reports Q2 adjusted EPS of $4.96, higher than estimate of
$4.70, and raises 2022 forecast for it to $19.00 to $21.25
urn:newsml:reuters.com:*:nBw2KM6H1a
** 15 of 17 brokerages rate the stock "buy" or higher, 2
"hold"; their median PT is $310
** Up to Wednesday's close, stock had fallen ~21% YTD
compared with a 15.6% decline in the S&P 500 index .SPX
(Reporting by Leroy Leo in Bengaluru)
((Leroy.Dsouza@thomsonreuters.com ; Twitter: https://twitter.com/LeroyLeo7;))